CareWare light 'patch' therapy for the treatment of acne vulgaris

Trial ID:
IRB-19-7346
E. Victor Ross, M.D.
This study is evaluating the effectiveness of combined blue and red light therapy as an “at home” treatment for moderate acne using wearable CareWare light patches. Study duration is about 6 weeks. Visits may be done in the clinic or by virtual/video visit.

Inclusion Criteria

Patients must:

  • Be 18 – 35 years of age

    Have a clinical diagnosis of moderate acne vulgaris

    Have at least 20 inflammatory lesions

    Be willing to avoid excess sun exposure and not use topical or oral anti-acne medications including medicated shampoo or soap during the study period

    Meet all other eligibility criteria

Exclusion Criteria

Patients must not:

  • Have used oral retinoid therapy such as isotretinoin within the past 12 months

    Have a diagnosis of psoriasis, seborrheic dermatitis or papulopustular rosacea

    Have a history of keloids

    Have an active infection

    Have tattoos or excess scarring in the treatment areas

    Be pregnant or planning to become pregnant, lactating, or nursing

Additional Info

CareWear light patches are wearable “stick and go” patches that are reusable and flexible. The patch uses patented LED light technology connected to a waterproof, rechargeable wireless controller that delivers a pre-programmed dosage of light.

Contact Info:

  • Dr. E. Victor Ross
  • ross.edward@scrippshealth.org
  • 858-764-9042